... tended to have history of IDU, whereas, female patients tended to have history of transfusion in this cohort of patients. At entry, 74.5% of patients presented with elevated ALT, and majority (59.4%) ... entering to the study. Author biography (continued from front page) Huiying Yang, MD, Ph.D, is the Director of Genetic Epidemiology Program, Cedars-Sinai Medical Center and Associate Professor of ... histology [11]. It is therefore necessary to determine which patients may benefit from the treatment. Extensive studies have focused on the natural history of HCV infection [12-23]. An early...